v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Cash flows from operating activities:        
Net income (loss) $ (74,721) $ 43,412 $ (241,052) $ 102,626
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization 91,854 87,127 274,395 254,973
Share-based compensation expenses 314,196 278,995 933,709 808,349
Amortization of deferred costs 44,830 35,482 126,515 100,844
Non-cash lease expense 23,359 21,407 68,318 64,706
(Gains) losses on investments (3,833) (25,222) 20,746 (125,479)
Other 3,251 4,408 15,373 (4,225)
Changes in operating assets and liabilities, net of business combinations:        
Trade and other receivables, net 61,885 6,649 200,008 171,257
Deferred costs (56,552) (50,654) (163,023) (129,758)
Prepaid expenses and other assets 2,435 18,050 (31,447) (21,047)
Accounts payable 18,116 (12,007) 20,884 (4,117)
Accrued expenses and other liabilities 47,061 2,498 41,253 (24,109)
Unearned revenue (63,213) (25,491) (302,936) (158,465)
Net cash provided by (used in) operating activities 408,668 384,654 962,743 1,035,555
Cash flows from investing activities:        
Purchases of marketable securities (2,310,915) (722,275) (5,651,005) (2,317,040)
Maturities of marketable securities 2,181,147 674,246 3,767,509 2,303,478
Sales of marketable securities 19,988 0 53,355 27,286
Owned real estate projects (181) (4) (446) (171,498)
Capital expenditures, excluding owned real estate projects (58,665) (33,335) (286,013) (190,912)
Business combinations, net of cash acquired 0 (60,645) 0 (739,865)
Purchase of other intangible assets (700) 0 (700) 0
Purchases of non-marketable equity and other investments (3,250) (26,720) (20,173) (84,526)
Sales and maturities of non-marketable equity and other investments 4,513 1,874 11,674 5,169
Other 0 0 0 1
Net cash provided by (used in) investing activities (168,063) (166,859) (2,125,799) (1,167,907)
Cash flows from financing activities:        
Proceeds from issuance of debt, net of debt discount 0 0 2,978,077 0
Repayments and extinguishment of debt (1,149,622) (9,384) (1,843,605) (28,205)
Payments for debt issuance costs 0 0 (7,220) 0
Proceeds from issuance of common stock from employee equity plans, net of taxes paid for shares withheld 710 1,894 85,002 76,381
Other (161) (33) (538) (409)
Net cash provided by (used in) financing activities (1,149,073) (7,523) 1,211,716 47,767
Effect of exchange rate changes (920) 50 (1,750) (85)
Net increase (decrease) in cash, cash equivalents, and restricted cash (909,388) 210,322 46,910 (84,670)
Cash, cash equivalents, and restricted cash at the beginning of period 2,497,043 1,092,929 1,540,745 1,387,921
Cash, cash equivalents, and restricted cash at the end of period 1,587,655 1,303,251 1,587,655 1,303,251
Supplemental cash flow data:        
Cash paid for interest 56,567 3,837 59,508 10,904
Cash paid for income taxes, net of refunds 2,093 2,716 9,863 9,150
Non-cash investing and financing activities:        
Purchases of property and equipment, accrued but not paid 68,028 49,713 68,028 49,713
Reconciliation of cash, cash equivalents, and restricted cash as shown in the Condensed Consolidated Statements of Cash Flows:        
Cash and cash equivalents 1,575,955 1,297,259 1,575,955 1,297,259
Restricted cash 11,700 5,992 11,700 5,992
Total cash, cash equivalents, and restricted cash $ 1,587,655 $ 1,303,251 $ 1,587,655 $ 1,303,251